Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial
The Lancet Respiratory Medicine (2022) - Comments
pubmed: 35123660  doi: 10.1016/s2213-2600(22)00006-6  issn: 2213-2600  issn: 2213-2619 

E Wesley Ely, Athimalaipet V Ramanan, Cynthia E Kartman, Stephanie De Bono, Ran Liao, Maria Lucia B Piruzeli, Jason D Goldman, José Francisco Kerr Saraiva, Sujatro Chakladar, Vincent C Marconi, Jorge Alatorre-Alexander, Javier David Altclas, Marcelo Casas, Valeria CevoliRecio, Todd Ellerin, Kleber Giovanni Luz, Jason D. Goldman, Maria Patelli Juliani Souza Lima, Akram Khan, Priscila Paulin